XML 48 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash Flows from Operating Activities:    
Net (loss) income $ (15,384) $ 3,758
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:    
Depreciation and amortization 15,798 22,149
Provision for doubtful accounts 9,370 13,392
Non-cash compensation 7,637 3,197
401(k) employer match 4,544 4,682
Loss on disposal of property and equipment 945 4,174
Gain on sale of care centers (184) (2,967)
Deferred income taxes (9,547) 6,357
Write off deferred debt issuance costs 2,513 488
Equity in earnings of equity investments (8,701) (2,234)
Amortization of deferred debt issuance costs 774 521
Return on equity investment 5,135 1,500
Asset impairment charge 77,268 2,208
Changes in operating assets and liabilities, net of impact of acquisitions:    
Patient accounts receivable (31,788) (5,848)
Other current assets 12,701 (1,885)
Other assets (803) 1,554
Accounts payable 8,597 668
U.S. Department of Justice settlement 0 (115,000)
Accrued expenses 9,152 (4,081)
Other long-term obligations (286) (2,762)
Net cash provided by (used in) operating activities 87,741 (70,129)
Cash Flows from Investing Activities:    
Proceeds from deferred compensation plan assets 1,077 9
Proceeds from the sale of property and equipment 0 3
Purchases of deferred compensation plan assets (19) (104)
Purchases of property and equipment (17,969) (9,882)
Purchase of investment (2,561) (3,421)
Proceeds from sale of investment 5,000 0
Acquisitions of businesses, net of cash acquired (5,800) 0
Proceeds from dispositions of care centers 413 4,233
Net cash used in investing activities (19,859) (9,162)
Cash Flows from Financing Activities:    
Proceeds from issuance of stock upon exercise of stock options and warrants 399 89
Proceeds from issuance of stock to employee stock purchase plan 1,591 1,875
Non-controlling interest distribution (300) 0
Proceeds from revolving line of credit 63,400 200,800
Repayments of revolving line of credit (78,400) (190,800)
Proceeds from issuance of long-term obligations 100,000 67,371
Debt issuance costs (2,553) (901)
Principal payments of long-term obligations (103,000) (10,904)
Net cash (used in) provided by financing activities (18,863) 67,530
Net increase (decrease) in cash and cash equivalents 49,019 (11,761)
Cash and cash equivalents at beginning of period 8,032 17,303
Cash and cash equivalents at end of period 57,051 5,542
Supplemental Disclosures of Cash Flow Information:    
Cash paid for interest 5,598 4,771
Cash paid for income taxes, net of refunds received (12,383) 13
Supplemental Disclosures of Non-Cash Financing and Investing Activities    
(Sale) acquistion of noncontrolling interests $ 0 $ (1,549)